Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-07

Clinical Trial Update: Manuka Honey Eye Drops VS Conventional Treatment of Meibomian Gland Dysfunction Related Dry Eye Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing Manuka honey eye drops to conventional treatment for Meibomian Gland Dysfunction-related dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Manuka honey eye drops

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Meibomian Gland Dysfunction | Phase 4 | Status: COMPLETED